NCT00005780View on ClinicalTrials.gov

Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 1, 2000

Primary Completion Date

June 9, 2021

Study Completion Date

June 16, 2021

Conditions
Mantle Cell LymphomaLymphoma, Mantle Cell
Interventions
DRUG

EPOCH-R

EPOCH-R for 6 cycles

BIOLOGICAL

GM-CSF

Granulocyte-macrophage colony-stimulating factor (GM-CSF) monthly with the vaccine for 5 doses

BIOLOGICAL

Idiotype vaccine

1 injection of vaccine monthly for 5 doses

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00005780 - Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma | Biotech Hunter | Biotech Hunter